Enrico Colli Selected Research

drospirenone

4/2022	Bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mg.
12/2021	Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4 mg drospirenone only in a 24/4 regimen and comparison to 0.075 mg desogestrel.
6/2020	Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.
3/2020	Safety, influence on the endometrium, sonographic changes and bleeding profile after 13 cycles with the new drospirenone only pill (DOP) for contraception.
1/2020	Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phase.
1/2020	A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen.
1/2020	Correction to: A multicenter, double-blind, randomized trial on the bleeding profle of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.
12/2019	Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
12/2019	A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrico Colli Research Topics

Disease

8	Hemorrhage 04/2022 - 12/2019
4	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 03/2007
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2009 - 01/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 03/2002
3	Lower Urinary Tract Symptoms 01/2013 - 02/2007
3	Overactive Urinary Bladder (Overactive Bladder) 07/2012 - 08/2007
2	Stroke (Strokes) 12/2021 - 12/2019
2	Myocardial Infarction 12/2021 - 12/2019
2	Cystitis 01/2013 - 03/2006
2	Hyperplasia 12/2012 - 02/2005
2	Inflammation (Inflammations) 03/2007 - 02/2007
2	Prostatitis 03/2007 - 02/2007
2	Hypertrophy 09/2006 - 02/2005
1	Amenorrhea 04/2022
1	Venous Thromboembolism 12/2021
1	Metrorrhagia (Spotting) 01/2020
1	Overweight 01/2020
1	Neglected Diseases 01/2018
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2018
1	Helminthiasis (Helminthiases) 01/2018
1	Onchocerciasis 01/2018
1	Activated Protein C Resistance (APC Resistance) 09/2016
1	Urinary Tract Infections (Urinary Tract Infection) 01/2013
1	Injection Site Reaction 01/2013
1	Pelvic Pain 02/2007
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 09/2006
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2006
1	Starvation 02/2005
1	Urinary Incontinence 01/2003

Drug/Important Bio-Agent (IBA)

9	drospirenone FDA LinkGeneric 04/2022 - 12/2019
8	BXL628IBA 07/2012 - 02/2005
4	Desogestrel FDA LinkGeneric 04/2022 - 12/2019
4	Progestins (Progestagens)IBA 04/2022 - 12/2019
3	Oral ContraceptivesIBA 04/2022 - 12/2019
3	Pharmaceutical PreparationsIBA 01/2018 - 08/2007
3	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2013 - 11/2011
3	AndrogensIBA 12/2012 - 02/2005
3	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2009 - 02/2007
3	rho-Associated KinasesIBA 04/2009 - 02/2007
3	Cholecalciferol (Vitamin D3)FDA Link 09/2006 - 01/2006
2	Estrogens (Estrogen)FDA Link 12/2021 - 12/2019
2	Goserelin (Zoladex)FDA Link 01/2013 - 12/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 06/2020
1	Combined Oral ContraceptivesIBA 12/2019
1	TabletsIBA 12/2019
1	AnthelminticsIBA 01/2018
1	Ivermectin (Mectizan)FDA Link 01/2018
1	Factor VIII (Coagulation Factor VIII)IBA 09/2016
1	Factor VII (Proconvertin)IBA 09/2016
1	fibrin fragment D (D-dimer)IBA 09/2016
1	Antithrombin IIIIBA 09/2016
1	Protein CIBA 09/2016
1	Hemostatics (Antihemorrhagics)IBA 09/2016
1	Androgen Antagonists (Antiandrogens)IBA 01/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2012
1	bicalutamide (Casodex)FDA LinkGeneric 12/2012
1	Testosterone (Sustanon)FDA Link 12/2012
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2011
1	NF-kappa B (NF-kB)IBA 04/2009
1	1,25-dihydroxyvitamin DIBA 03/2007
1	CalciumIBA 02/2007
1	ChemokinesIBA 02/2007
1	Biomarkers (Surrogate Marker)IBA 02/2007
1	CytokinesIBA 02/2007
1	Interleukin-8 (Interleukin 8)IBA 02/2007
1	Vitamin D FDA LinkGeneric 09/2006
1	Calcitriol (Calcijex)FDA LinkGeneric 03/2006
1	Therapeutic UsesIBA 03/2006
1	AllergensIBA 03/2006
1	Interleukin-13IBA 03/2006
1	Peptide Hydrolases (Proteases)FDA Link 03/2006
1	Proteins (Proteins, Gene)FDA Link 02/2005
1	VimentinIBA 02/2005
1	DesminIBA 02/2005
1	ORALIT (ORS)IBA 03/2002

Therapy/Procedure

5	Contraception (Birth Control) 12/2021 - 12/2019
4	Therapeutics 12/2012 - 01/2003
1	Ovulation Inhibition 06/2020
1	Duration of Therapy 11/2011
1	Conservative Treatment 01/2003